To this end, a homodimeric His6-C9-C9-Cys construct (Fig. 1c-iii) was assembled to assess the immunohistochemical capacity of this construct to detect CEA in human pancreatic cancer specimens. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.